Other official information and services: www.belgium.be
Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2025C513 Product name: Repotrectinib en/of farmaceutisch aanvaardbare zouten en esters daarvan
Basic information
- Application number:
- 2025C/513
- Type:
- Certificate
- SPC type:
- Medical
- Basic patent number:
- 191690411
- Status:
- Open
- Publication number:
- 2025C513
- 1rst applicant's nationality:
- Procedural language:
- Dutch
Marketing authorization
- Marketing authorization number:
- EU/1/24/1883
- Marketing authorization type:
- National/EU
- Designates country:
- No
- Marketing authorization date:
- 14/01/2025
- Marketing authorization status:
- Accepted
- Marketing authorization country:
- Belgium (BE)
Dates
- Filing date:
- 13/03/2025
- First marketing authorization date:
- 14/01/2025
- Grant date:
- Activation date:
- BE Publication date:
- 31/03/2025
- Lapsed date:
- Expiration date (if granted and all annual fees paid):
- Basic SPC Expiration (if granted and all annual fees paid):
- 14/01/2040
- SPC/SPC Extension Expiration (if granted and all annual fees paid):
- Rejection date:
- Withdrawal date:
Applicant
- Name:
- Turning Point Therapeutics, Inc.
- Legal Form:
- Inc.
- From:
- 14/03/2025
- Address:
- Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)
- To:
Agent
- Name:
- NLO
- Legal Form:
- From:
- 14/03/2025
- Address:
- New Babylon City Offices Anna van Buerenplein 21A, 2595 DA DEN HAAG, Netherlands (NL)
- To:
| Filing date | Document type | Publication Type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|---|
| 13/03/2025 | Application Form | 4 | /4/4/6/8/1/0722518644/docs/2025c513_0_applicationform_20250314_084541314.pdf | ||||
| 13/03/2025 | MA Official Publication | Official Publication of 1st Marketing Authorization | 1 | /4/4/6/8/1/0722518644/docs/2025c513_1_maofficialpublication_20250314_084541028.pdf | |||
| 13/03/2025 | Abstract Product Characteristics | Abstract of the characteristics of the product | 24 | /4/4/6/8/1/0722518644/docs/2025c513_2_abstractproductcharacteristics_20250314_084539529.pdf | |||
| 13/03/2025 | Marketing Authorization | 1st Marketing Authorization (EU) | 3 | /4/4/6/8/1/0722518644/docs/2025c513_3_marketingauthorization_20250314_084538614.pdf | |||
| 13/03/2025 | General Document | Other | 1 | /4/4/6/8/1/0722518644/docs/2025c513_4_generaldocument_20250314_084538474.pdf | |||
| 31/03/2025 | Publication | I1 | 1 | /4/4/6/8/1/0722518644/docs/2025c513_5_i1document_20250331_142853090.pdf |